Advertisement
U.S. markets open in 2 hours 40 minutes
  • S&P Futures

    5,305.75
    -2.50 (-0.05%)
     
  • Dow Futures

    40,141.00
    -3.00 (-0.01%)
     
  • Nasdaq Futures

    18,492.25
    -11.50 (-0.06%)
     
  • Russell 2000 Futures

    2,136.70
    -1.70 (-0.08%)
     
  • Crude Oil

    82.09
    +0.74 (+0.91%)
     
  • Gold

    2,230.00
    +17.30 (+0.78%)
     
  • Silver

    24.80
    +0.05 (+0.19%)
     
  • EUR/USD

    1.0792
    -0.0037 (-0.35%)
     
  • 10-Yr Bond

    4.1960
    0.0000 (0.00%)
     
  • Vix

    12.96
    +0.18 (+1.41%)
     
  • GBP/USD

    1.2616
    -0.0022 (-0.18%)
     
  • USD/JPY

    151.3730
    +0.1270 (+0.08%)
     
  • Bitcoin USD

    70,620.75
    +633.79 (+0.91%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,957.99
    +26.01 (+0.33%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Earnings roundup: Huntsman, Marsh & McLennan

Earnings roundup: Huntsman posts 4Q loss; Marsh & McLennan revenue, profit meet St. view

Among the earnings stories for Tuesday, Feb. 12, from The Associated Press:

— Shares of Huntsman slid after the chemical maker posted a fourth-quarter loss, hurt by restructuring costs and a loss on paying down debt.

— Marsh & McLennan Cos., a consulting and professional services firm, reported revenue and profit for the fourth quarter that met market expectations.

— Fidelity National Information Services Inc. said its fourth-quarter net income climbed 17 percent, free of impairment charges as revenue for its financial solutions segment increased.

— Capella Education Co. shares slipped after the online education company reported a drop in fourth-quarter revenue and profit due to lower enrollments.

— Vanda Pharmaceuticals Inc. took a wider fourth-quarter loss as it spent more money to develop an experimental sleep-disorder drug, and revenue from a schizophrenia drug slipped.

Advertisement